W P97 (Primaquine phosphate 26.3 mg (15 mg base))
Pill imprint W P97 has been identified as Primaquine phosphate 26.3 mg (15 mg base).
Primaquine is used in the treatment of pneumocystis pneumonia; malaria prevention; malaria and belongs to the drug class antimalarial quinolines. FDA has not classified the drug for risk during pregnancy. Primaquine 26.3 mg (15 mg base) is not a controlled substance under the Controlled Substance Act (CSA).
- W P97
- 26.3 mg (15 mg base)
- Prescription only
- Drug Class:
- Antimalarial quinolines
- Pregnancy Category:
- N - Not classified
- CSA Schedule:
- Not a controlled drug
- National Drug Code (NDC):
- Inactive Ingredients:
- carnauba wax
polyethylene glycol 400
ferric oxide red
hypromellose 2910 (15000 mPa.s)
Note: Inactive ingredients may vary.
|NDC Code||Manufacturer / Repackager|
|43063-0225||PDRX Pharmaceuticals Inc (repackager)|
More about primaquine
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: antimalarial quinolines
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.